Results 41 to 50 of about 80,877 (282)

Rapid widespread distribution of intranasal naloxone for overdose prevention [PDF]

open access: yes, 2017
Background: In order to have a substantial impact on overdose prevention, the expansion and scalingup of overdose prevention with naloxone distribution (OPEND) programs are needed.
Lobmaier, Philipp Paul   +2 more
core   +1 more source

If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study

open access: yesBMC Public Health, 2022
Background Expanding access to the opioid antagonist naloxone to reduce overdose mortality is a public health priority in the United States. Naloxone standing orders (NSOs) have been established in many states to increase naloxone dispensing at ...
Susannah Slocum   +4 more
doaj   +1 more source

Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial

open access: yesPharmacy, 2022
The number of opioid-related deaths in Canada has steadily increased since 2016 and the COVID-19 pandemic has worsened this trend. Naloxone has been pivotal for reducing opioid-related harms and death, and pharmacists play a crucial role in ensuring the ...
Ashley Cid   +5 more
doaj   +1 more source

Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.

open access: yesJAMA Internal Medicine, 2019
Importance Given high rates of opioid-related fatal overdoses, improving naloxone access has become a priority. States have implemented different types of naloxone access laws (NALs) and there is controversy over which of these policies, if any, can curb
Rahi Abouk, R. Pacula, David Powell
semanticscholar   +1 more source

Systems analysis and improvement approach to improve naloxone distribution within syringe service programs: study protocol of a randomized controlled trial

open access: yesImplementation Science, 2023
Background More than half a million Americans died of an opioid-related overdose between 1999 and 2020, the majority occurring between 2015 and 2020. The opioid overdose mortality epidemic disproportionately impacts Black, Indigenous, and people of color
Christopher F. Akiba   +8 more
doaj   +1 more source

Method for Successfully Inducting Individuals who use Illicit Fentanyl onto Buprenorphine/naloxone

open access: yesAmerican Journal on Addictions, 2020
Background and Objectives: Individuals exposed to fentanyl are at risk of precipitated withdrawal using typical buprenorphine/naloxone induction procedures.
Denis G. Antoine   +6 more
semanticscholar   +1 more source

Clinical Pharmacokinetics and Pharmacodynamics of Naloxone

open access: yesClinical Pharmacokinetics
Naloxone is a World Health Organization (WHO)-listed essential medicine and is the first choice for treating the respiratory depression of opioids, also by lay-people witnessing an opioid overdose.
Teijo I. Saari, John Strang, Ola Dale
semanticscholar   +1 more source

Naloxone Availability and Cost After Transition to an Over-the-Counter Product

open access: yesJAMA Health Forum
Key Points Question How did pharmacy-based access to naloxone and quoted out-of-pocket cost for naloxone change after naloxone became available as an over-the-counter (OTC) product?
G. Marley   +4 more
semanticscholar   +1 more source

Differential Changes in Expression of Stress- and Metabolic-related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal [PDF]

open access: yes, 2013
Chronic morphine treatment and naloxone precipitated morphine withdrawal activates stress-related brain circuit and results in significant changes in food intake, body weight gain and energy metabolism.
Nunez, Cristina   +13 more
core   +1 more source

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses

open access: yesDrug and Alcohol Dependence Reports, 2023
Background: Expanding access to naloxone is one of the most impactful interventions in decreasing opioid-related mortality. However, state distribution rates of naloxone are insufficient to meet community need.
Robert M. Bohler   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy